AstraZeneca launches new partnership to improve care for patients with non-communicable diseases

(VEN) - Cardiovascular, diabetes and renal diseases account for most of the local non-communicable diseases (NCDs) and fatality burden, with a relatively high co-morbidity rate. Early diagnosis and treatment are critical to ensure an effective management